Accordingly, the studies on Pax5/- and Sca1-ETV6-Runx1 mice have permitted the demonstration, for the first time, of the key role of genetic factors in contributing to affecting GM and how such variations can impact HS and leukemia development. This evidence concerns the gene PAX5 and leukemia.